Literature DB >> 7398679

Qualitative and quantitative determination of drotaverine metabolites in rat bile.

Z Vargay, G Simon, M Winter, T Szüts.   

Abstract

After oral and intravenous administration of drotaverin-14C its metabolites were determined in rat bile. Three major metabolites were identified by tlc. All the metabolites appeared in conjugated form. No unchanged drotaverine was detectable in the bile, except after treatment with doses much in excess of the therapeutic range. The ratio of major metabolites to unchanged product was determined by two-dimensional densitometry using a Telechrom Video Densitometer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398679     DOI: 10.1007/BF03189448

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  Data on the metabolism of benzylisoquinoline derivatives. The metabolism of drotaverin.

Authors:  L Gyarmati; A Dávid; Z Mészáros; I Rácz; P Szentmiklósi
Journal:  Pharmazie       Date:  1975-03       Impact factor: 1.267

2.  COMPARATIVE CLINICAL STUDY OF THE POTENCY OF SPASMOLYTICS (OBSERVATIONS REGARDING THE CLINICAL PHARMACOLOGY OF NO-SPA).

Authors:  G PETRANYI; G D SZEGEDI
Journal:  Ther Hung       Date:  1963

3.  [THE EFFECTS OF 6,7,3',4'-TETRAETHOXY-1, 2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE ON CORONARY CIRCULATION].

Authors:  G GABOR; G SOMOGYI
Journal:  Arzneimittelforschung       Date:  1964-09

4.  Species differences in the excretion of papaverine metabolites.

Authors:  F M Belpaire; M G Bogaert
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-04

5.  The excretion of 3H-papaverine in the rat.

Authors:  F M Belpaire; M G Bogaert
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

6.  Metabolism of papaverine. I. Identification of metabolites in rat bile.

Authors:  F M Belpaire; M G Bogaert; M T Rosseel; M Anteunis
Journal:  Xenobiotica       Date:  1975-07       Impact factor: 1.908

7.  Metabolism of papaverine. III. Effect of phenobarbital, 3-methylcholanthrene and SKF 525-A pre-treated in vivo and in vitro.

Authors:  F M Belpaire; M G Bogaert
Journal:  Xenobiotica       Date:  1975-07       Impact factor: 1.908

8.  Absorption, distribution and elimination of drotaverine.

Authors:  K Magyar; M Lengyel; J Knoll
Journal:  Acta Physiol Acad Sci Hung       Date:  1978
  8 in total
  2 in total

1.  Pharmacokinetics and bioavailability of drotaverine in humans.

Authors:  O O Bolaji; C O Onyeji; A O Ogundaini; T A Olugbade; F A Ogunbona
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

2.  The fate of drotaverine-acephyllinate in rat and man. II. Human pharmacokinetics of drotaverine-14C-acephyllinate.

Authors:  Z Vargay; T Deutsch; I Szatmári; T Szüts; P Várkonyi; S Kerpel-Fronius; S Eckhardt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.